as a first clinical trial of a fluoroquinolone derivative in leprosy , ten previously untreated lepromatous leprosy patients , about two fifths of them with primary dapsone resistance but all susceptible to rifampin , were treated with pefloxacin 400 mg twice daily for 6 months .
C0023343
leprosy
C0035608
rifampin